Key facts
- Zelira HOPE 1 SPV’s last known valuation is $66.0M (Jan 2026).
- It has raised $41.6M; the latest was PE Growth/Expansion ($33.0M) in Jan 2026.
- Notable investors include Cantheon Capital, ThirdGate Capital Global Management.
- Status: Privately Held (backing).
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Zelira HOPE 1 SPV
- ·The full record, as it builds
Funding rounds
No funding rounds for Zelira HOPE 1 SPV are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Zelira HOPE 1 SPV
Provider of mental health and rehabilitation services based in Australia, intended to serve individuals with depression, anxiety, and addiction. The company offers structured therapy programs, psychiatric consultations, and personalized recovery plans for patients and families, thereby enabling holistic care and improved emotional well-being.
- Sector
- Healthcare
- HQ
- Perth, Australia
- Website
- zelirahope.com/
- Ownership
- Privately Held (backing)
Zelira HOPE 1 SPV doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Zelira HOPE 1 SPV shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Zelira HOPE 1 SPV in its N-PORT filings yet. We sweep new filings monthly.